How Long Does Deep Brain Stimulation Give Patients Benefit?

IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY
Esin Bulut MS , P. Mitchell Johansen MD , Alya Elbualy BS , Cheyenne Kalman BS , Ryan Mayer , Nicholas Kato BS , Rodrigo Salmeron de Toledo Aguiar MD , Julie G. Pilitsis MD, PhD, MBA
{"title":"How Long Does Deep Brain Stimulation Give Patients Benefit?","authors":"Esin Bulut MS ,&nbsp;P. Mitchell Johansen MD ,&nbsp;Alya Elbualy BS ,&nbsp;Cheyenne Kalman BS ,&nbsp;Ryan Mayer ,&nbsp;Nicholas Kato BS ,&nbsp;Rodrigo Salmeron de Toledo Aguiar MD ,&nbsp;Julie G. Pilitsis MD, PhD, MBA","doi":"10.1016/j.neurom.2024.05.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>One of the most common questions patients ask when they are contemplating deep brain stimulation (DBS) is how long it will last. To guide physicians in answering this query, we performed a scoping review to assess the current state of the literature and to identify the gaps that need to be addressed.</div></div><div><h3>Materials and Methods</h3><div>The authors performed a MEDLINE search inclusive of articles from January 1987 (advent of DBS literature) to June 2023 including human and modeling studies written in English. For longevity of therapy data, only studies with a mean follow-up of ≥three years were included. Using the Rayyan platform, two reviewers (JP and RM) performed a title screen. Of the 734 articles, 205 were selected by title screen and 109 from abstract review. Ultimately, a total of 122 articles were reviewed. The research questions we explored were 1) how long can the different components of the DBS system maintain functionality? and 2) how long can DBS remain efficacious in treating Parkinson’s disease (PD), essential tremor (ET), dystonia, and other disorders?</div></div><div><h3>Results</h3><div>We showed that patients with PD, ET, and dystonia maintain a considerable long-term benefit in motor scores seven to ten years after implant, although the percentage improvement decreases over time. Stimulation off scores in PD and ET show worsening, consistent with disease progression. Battery life varies by the disease treated and the programming settings used. There remains a paucity of literature after ten years, and the impact of new device technology has not been classified to date.</div></div><div><h3>Conclusion</h3><div>We reviewed existing data on DBS longevity. Overall, outcomes data after ten years of therapy are substantially limited in the current literature. We recommend that physicians who have data for patients with DBS exceeding this duration publish their results.</div></div>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":"28 3","pages":"Pages 472-483"},"PeriodicalIF":3.2000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuromodulation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1094715924001284","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

One of the most common questions patients ask when they are contemplating deep brain stimulation (DBS) is how long it will last. To guide physicians in answering this query, we performed a scoping review to assess the current state of the literature and to identify the gaps that need to be addressed.

Materials and Methods

The authors performed a MEDLINE search inclusive of articles from January 1987 (advent of DBS literature) to June 2023 including human and modeling studies written in English. For longevity of therapy data, only studies with a mean follow-up of ≥three years were included. Using the Rayyan platform, two reviewers (JP and RM) performed a title screen. Of the 734 articles, 205 were selected by title screen and 109 from abstract review. Ultimately, a total of 122 articles were reviewed. The research questions we explored were 1) how long can the different components of the DBS system maintain functionality? and 2) how long can DBS remain efficacious in treating Parkinson’s disease (PD), essential tremor (ET), dystonia, and other disorders?

Results

We showed that patients with PD, ET, and dystonia maintain a considerable long-term benefit in motor scores seven to ten years after implant, although the percentage improvement decreases over time. Stimulation off scores in PD and ET show worsening, consistent with disease progression. Battery life varies by the disease treated and the programming settings used. There remains a paucity of literature after ten years, and the impact of new device technology has not been classified to date.

Conclusion

We reviewed existing data on DBS longevity. Overall, outcomes data after ten years of therapy are substantially limited in the current literature. We recommend that physicians who have data for patients with DBS exceeding this duration publish their results.
脑深部刺激能让患者受益多久?
导言:患者在考虑接受脑深部刺激(DBS)时最常问的一个问题是,这种刺激能持续多长时间。为了指导医生回答这个问题,我们进行了一次范围综述,以评估文献的现状,并找出需要解决的差距:作者在 MEDLINE 上检索了从 1987 年 1 月(DBS 文献问世)到 2023 年 6 月的文章,包括用英语撰写的人体和模型研究。对于治疗寿命数据,只纳入了平均随访时间≥三年的研究。两位审稿人(JP 和 RM)使用 Rayyan 平台进行了标题筛选。在 734 篇文章中,205 篇通过标题筛选,109 篇通过摘要审查。最终,共审阅了 122 篇文章。我们探讨的研究问题是:1)DBS 系统的不同组件能在多长时间内保持功能? 2)DBS 在治疗帕金森病 (PD)、本质性震颤 (ET)、肌张力障碍和其他疾病方面能在多长时间内保持疗效?我们的研究表明,帕金森病、ET 和肌张力障碍患者在植入 DBS 七到十年后,其运动评分仍能保持可观的长期疗效,尽管改善的百分比会随着时间的推移而降低。帕金森氏症和ET患者的刺激关闭评分随着疾病的进展而恶化。电池寿命因治疗的疾病和使用的程序设置而异。十年后的文献仍然很少,新设备技术的影响至今尚未分类:我们回顾了有关 DBS 寿命的现有数据。总的来说,目前的文献中,治疗十年后的结果数据非常有限。我们建议那些掌握了超过这一疗程的 DBS 患者数据的医生公布他们的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuromodulation
Neuromodulation 医学-临床神经学
CiteScore
6.40
自引率
3.60%
发文量
978
审稿时长
54 days
期刊介绍: Neuromodulation: Technology at the Neural Interface is the preeminent journal in the area of neuromodulation, providing our readership with the state of the art clinical, translational, and basic science research in the field. For clinicians, engineers, scientists and members of the biotechnology industry alike, Neuromodulation provides timely and rigorously peer-reviewed articles on the technology, science, and clinical application of devices that interface with the nervous system to treat disease and improve function.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信